PRAN

Prana Biotechnology Ltd News Headlines

$1.91
*  
0.035
1.8%
Get PRAN Alerts
*Delayed - data as of Oct. 24, 2014  -  Find a broker to begin trading PRAN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Genervon ALS drug shows encouraging results
10/20/2014 8:27:00 AM - Seeking Alpha


Horizon Pharma's Actimmune Gets Orphan Drug Designation - Analyst Blog
10/7/2014 2:00:00 PM - Zacks.com


Prana Biotechnology Up on Orphan Drug Status for PBT2 - Analyst Blog
9/8/2014 5:35:00 PM - Zacks.com


Sector Update: Health Care Stocks Starting to Rise; Prana Biotechnology Soars After Huntington's Medication Receives Orphan Drug Statis
9/5/2014 1:39:16 PM - MT Newswires


Sector Update: Health Care
9/5/2014 1:38:55 PM - MT Newswires


U.S. Hot Stocks: Hot Stocks to Watch
9/5/2014 9:34:00 AM - Dow Jones Business News


Prana Gets FDA Orphan Drug Designation For PBT2 For Huntington Disease
9/5/2014 7:55:00 AM - RTT News


Prana Biotechnology Leads Gains Among Asian ADRs to Rebound From Biotech Selling Pressure
7/17/2014 12:12:56 PM - MT Newswires


Rediff.com Declines Alongside Asian ADRs as U.S. Stocks Retreat From Record Close
6/3/2014 10:59:45 AM - MT Newswires


Prana Biotechnology Is Still A Short After Recent Alzheimer's Failure
4/14/2014 4:15:00 PM - Seeking Alpha


Are These Three Biotech Companies Still Worth A Gamble?
4/14/2014 11:16:00 AM - Seeking Alpha


US Futures Gain At Quarter-End Before Yellen Speaks; J&J Takes $4 Bln Bid For Ortho-Clinical Unit
3/31/2014 9:06:54 AM - MT Newswires


Sector Update: Healthcare Shares Flat in Pre-Market; Novartis Rallies 4% on Conclusion of Chronic Heart Failure Treatment Study
3/31/2014 8:24:42 AM - MT Newswires


Sector Update: Healthcare
3/31/2014 8:24:12 AM - MT Newswires


US Stocks Poised to End Quarter On High Note as Fed Chair Yellen to Speak
3/31/2014 8:23:04 AM - MT Newswires


Alzheimer's Dementia: Eli Lilly's Solanezumab Or Prana's PBT2, Which Would You Take?
3/4/2014 3:24:00 PM - Seeking Alpha


Prana: Right Drug, Wrong Dose
3/3/2014 9:38:00 AM - Seeking Alpha


Bipolar Prana: PBT2 For Alzheimer's Dementia, Implications Of The Upcoming IMAGINE Trial Results
3/1/2014 6:45:00 AM - Seeking Alpha


Following The Latest In Alzheimer's Research As An Investor
2/24/2014 10:12:00 AM - Seeking Alpha


Positive Phase 2 Results For Prana Biotechnology In Huntington's Disease: Behind The Smoke And Mirrors
2/22/2014 12:45:00 PM - Seeking Alpha


SA PRO: Top Long And Short Ideas, Thursday February 20
2/21/2014 7:30:00 AM - Seeking Alpha


Prana Biotechnology And MannKind Corp.: Bad News Obeys Its Own Special Laws
2/20/2014 12:33:00 PM - Seeking Alpha


Company news for February 19, 2014 - Corporate Summary
2/19/2014 11:06:01 AM - Zacks.com


Synthetic Biologics Under The Radar With Upcoming Multiple Sclerosis Data Catalyst
2/19/2014 7:55:00 AM - Seeking Alpha


Prana: Expect Success In Massive Binary Event
2/18/2014 1:19:00 PM - Seeking Alpha